A group of researchers from the Parc Taulí Research and Innovation Institute (I3PT) has collaborated in an important European study that has evaluated theefficacy of the combination of two drugs, sim...
Read moreThe second phase of construction of the new research and innovation building at Parc Taulí is completed
Read moreThe Institute will be present at 4 Years From Now (4YFN), within the framework of the Mobile World Congress, with the aim of facilitating access for companies and professionals to the project and fost...
Read moreThe Parc Taulí Research and Innovation Institute (I3PT) has obtained a total of 2.604.000 Euros in competitive funding to develop sixteen health research and innovation projects
Read moreA work published in theAmerican Journal of Respiratory and Critical Care Medicine, in collaboration with I3PT, highlights critical gaps in the detection and management of sepsis in European hospitals ...
Read moreThe study has allowed identify a new strain of Helicobacter pylori which can be key to deepening the mechanisms that trigger this type of cancer. In addition, it will facilitate the development of new...
Read moreThe study combines the analysis of blood markers, which reflect the metabolic state of the tissues, with the direct monitoring of cardiac function using invasive catheters
Read moreIt is a unique treatment strategy in the healthcare field, based on non-invasive electrical stimulation to maintain the strength of respiratory muscles in patients requiring mechanical ventilation sup...
Read moreThe main objective is to demonstrate that this technology not only generates benefits for the patient, but also reduces time and saves resources in the medical center
Read moreThe treatment, successfully tested in mice, will be the basis of a future clinical trial by the biopharmaceutical company Kriya Therapeutics, Inc. ("Kriya")
Read moreThis type of vaccine uses the body's own immune system to attack proteins that abnormally accumulate in the brain and are linked to neuronal degeneration
Read moreLIFE GENESYS will allow the development of a preventive resistance risk warning platform —one of the main challenges facing medicine today— which will help manage the environmental impact derived ...
Read more